Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors.

Jiang J, Wu X, Tang H, Luo G.

PLoS One. 2013 Jul 2;8(7):e67982. doi: 10.1371/journal.pone.0067982. Print 2013.

2.

Hepatitis C virus attachment mediated by apolipoprotein E binding to cell surface heparan sulfate.

Jiang J, Cun W, Wu X, Shi Q, Tang H, Luo G.

J Virol. 2012 Jul;86(13):7256-67. doi: 10.1128/JVI.07222-11. Epub 2012 Apr 24.

3.

Characterization of hepatitis C virus interaction with heparan sulfate proteoglycans.

Xu Y, Martinez P, Séron K, Luo G, Allain F, Dubuisson J, Belouzard S.

J Virol. 2015 Apr;89(7):3846-58. doi: 10.1128/JVI.03647-14. Epub 2015 Jan 21.

4.

Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes.

Shi Q, Jiang J, Luo G.

J Virol. 2013 Jun;87(12):6866-75. doi: 10.1128/JVI.03475-12. Epub 2013 Apr 10.

5.

Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding.

Liu S, McCormick KD, Zhao W, Zhao T, Fan D, Wang T.

Hepatology. 2012 Aug;56(2):484-91. doi: 10.1002/hep.25665. Epub 2012 Jul 2.

6.

Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.

Ji ZS, Brecht WJ, Miranda RD, Hussain MM, Innerarity TL, Mahley RW.

J Biol Chem. 1993 May 15;268(14):10160-7.

8.

Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein E.

Lefèvre M, Felmlee DJ, Parnot M, Baumert TF, Schuster C.

PLoS One. 2014 Apr 21;9(4):e95550. doi: 10.1371/journal.pone.0095550. eCollection 2014.

9.

Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection.

Yang Z, Wang X, Chi X, Zhao F, Guo J, Ma P, Zhong J, Niu J, Pan X, Long G.

J Virol. 2016 Oct 14;90(21):9632-9643. Print 2016 Nov 1.

11.

Roles of human apolipoprotein E in the infectivity and replication of hepatitis C virus genotype 2a.

Jung BK, Kim HR, Park GN, Luo G, Chang KS.

J Microbiol. 2016 Jun;54(6):451-8. doi: 10.1007/s12275-016-6099-3. Epub 2016 May 27.

PMID:
27225463
12.

Two-step mechanism of binding of apolipoprotein E to heparin: implications for the kinetics of apolipoprotein E-heparan sulfate proteoglycan complex formation on cell surfaces.

Futamura M, Dhanasekaran P, Handa T, Phillips MC, Lund-Katz S, Saito H.

J Biol Chem. 2005 Feb 18;280(7):5414-22. Epub 2004 Dec 6.

13.

Binding of rat thyroglobulin to heparan sulfate proteoglycans.

Marinò M, Andrews D, McCluskey RT.

Thyroid. 2000 Jul;10(7):551-9.

PMID:
10958307
14.

Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.

Zhang F, Sodroski C, Cha H, Li Q, Liang TJ.

Gastroenterology. 2017 Jan;152(1):257-270.e7. doi: 10.1053/j.gastro.2016.09.033. Epub 2016 Sep 30.

PMID:
27693511
15.

New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E.

Libeu CP, Lund-Katz S, Phillips MC, Wehrli S, Hernáiz MJ, Capila I, Linhardt RJ, Raffaï RL, Newhouse YM, Zhou F, Weisgraber KH.

J Biol Chem. 2001 Oct 19;276(42):39138-44. Epub 2001 Aug 10.

16.
17.
18.

Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.

Andréo U, Maillard P, Kalinina O, Walic M, Meurs E, Martinot M, Marcellin P, Budkowska A.

Cell Microbiol. 2007 Oct;9(10):2445-56. Epub 2007 May 21.

PMID:
17517063
20.

Supplemental Content

Support Center